The pursuit of oncotargets through understanding defective cell regulation
Metrics: PDF 1837 views | HTML 2304 views | ?
Received: April 29, 2010, Accepted: October 18, 2010, Published: October 18, 2010More effective anticancer agents are essential, as has too often been demonstrated by the paucity of therapeutics which preserve life. Their discovery is very difficult. Many approaches are being applied, from testing folk medicines to automated high throughput screening of large chemical libraries. Mutations in cancer cells create dysfunctional regulatory systems. This Perspective summarizes an approach to applying defective molecular control mechanisms as oncotargets on which drug discoveries against cancer can be based.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.